Commentary: What to do with irritability? Do not give it a new diagnostic home-a commentary on Evans et al. (2020) / Mary A. FRISTAD in Journal of Child Psychology and Psychiatry, 62-3 (March 2021)  

Public ISBD [article]  inJournal of Child Psychology and Psychiatry > 62-3 (March 2021) . - p.313-315 Titre : Commentary: What to do with irritability? Do not give it a new diagnostic home-a commentary on Evans et al. (2020) Type de document : texte imprimé Auteurs : Mary A. FRISTAD, Auteur Article en page(s) : p.313-315 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : Irritability is ubiquitous and therefore nonspecific. Evans and colleagues conducted an international study to test clinicians' ability to differentiate chronic irritability from four 'boundary' presentations: nonirritable oppositionality, episodic bipolar disorder irritability, depressive disorders, and normative irritability. Clinicians assigned to rate vignettes according to the International Classification of Diseases and Related Health Problems-Eleventh Revision (ICD-11) fared best, while those assigned to the Diagnostic and Statistical Manual-5th Edition (DSM-5) condition had the most false positives and false negatives. Findings are consistent with a decade's worth of investigation on the utility of irritability as a diagnostic criterion. Irritability is commonly associated with both internalizing and externalizing disorders. Multiple investigations of its new 'home' within the DSM-5 categorical diagnosis of DMDD indicate a poor fit. Irritability is more useful as a specifier for other disorders, consistent with how it is utilized within the ICD-11. En ligne : http://dx.doi.org/10.1111/jcpp.13354 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=443 [article] Commentary: What to do with irritability? Do not give it a new diagnostic home-a commentary on Evans et al. (2020) [texte imprimé] / Mary A. FRISTAD, Auteur . - p.313-315. Langues : Anglais (eng) in Journal of Child Psychology and Psychiatry > 62-3 (March 2021) . - p.313-315 Index. décimale : PER Périodiques Résumé : Irritability is ubiquitous and therefore nonspecific. Evans and colleagues conducted an international study to test clinicians' ability to differentiate chronic irritability from four 'boundary' presentations: nonirritable oppositionality, episodic bipolar disorder irritability, depressive disorders, and normative irritability. Clinicians assigned to rate vignettes according to the International Classification of Diseases and Related Health Problems-Eleventh Revision (ICD-11) fared best, while those assigned to the Diagnostic and Statistical Manual-5th Edition (DSM-5) condition had the most false positives and false negatives. Findings are consistent with a decade's worth of investigation on the utility of irritability as a diagnostic criterion. Irritability is commonly associated with both internalizing and externalizing disorders. Multiple investigations of its new 'home' within the DSM-5 categorical diagnosis of DMDD indicate a poor fit. Irritability is more useful as a specifier for other disorders, consistent with how it is utilized within the ICD-11. En ligne : http://dx.doi.org/10.1111/jcpp.13354 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=443

Development of bipolar disorder and other comorbidity among youth with attention-deficit/hyperactivity disorder / L. Eugene ARNOLD in Journal of Child Psychology and Psychiatry, 61-2 (February 2020)  

Public ISBD [article]  inJournal of Child Psychology and Psychiatry > 61-2 (February 2020) . - p.175-181 Titre : Development of bipolar disorder and other comorbidity among youth with attention-deficit/hyperactivity disorder Type de document : texte imprimé Auteurs : L. Eugene ARNOLD, Auteur ; Anna R. VAN METER, Auteur ; Mary A. FRISTAD, Auteur ; Eric A. YOUNGSTROM, Auteur ; Boris BIRMAHER, Auteur ; Robert L. FINDLING, Auteur ; Sarah M. HORWITZ, Auteur ; Sarah R. BLACK, Auteur Article en page(s) : p.175-181 Langues : Anglais (eng) Mots-clés : Attention-deficit/hyperactivity disorder  bipolar disorder  comorbidity Index. décimale : PER Périodiques Résumé : OBJECTIVE: To examine development of bipolar spectrum disorders (BPSD) and other disorders in prospectively followed children with attention-deficit/hyperactivity disorder (ADHD). METHOD: In the Longitudinal Assessment of Manic Symptoms (LAMS) study, 531 of 685 children age 6-12 (most selected for scores > 12 on General Behavior Inventory 10-item Mania scale) had ADHD, 112 with BPSD, and 419 without. With annual assessments for 8 years, retention averaged 6.2 years. Chi-square analyses compared rate of new BPSD and other comorbidity between those with versus without baseline ADHD and between retained versus resolved ADHD diagnosis. Cox regression tested factors influencing speed of BPSD onset. RESULTS: Of 419 with baseline ADHD but not BPSD, 52 (12.4%) developed BPSD, compared with 16 of 110 (14.5%) without either baseline diagnosis. Those who developed BPSD had more nonmood comorbidity over the follow-up than those who did not develop BPSD (p = .0001). Of 170 who still had ADHD at eight-year follow-up (and not baseline BPSD), 26 (15.3%) had developed BPSD, compared with 16 of 186 (8.6%) who had ADHD without BPSD at baseline but lost the ADHD diagnosis (chi(2) = 3.82, p = .051). There was no statistical difference in whether ADHD persisted or not across new BPSD subtypes (chi(2) = 1.62, p = .446). Of those who developed BPSD, speed of onset was not significantly related to baseline ADHD (p = .566), baseline anxiety (p = .121), baseline depression (p = .185), baseline disruptive behavior disorder (p = .184), age (B = -.11 p = .092), maternal mania (p = .389), or paternal mania (B = .73, p = .056). Those who started with both diagnoses had more severe symptoms/impairment than those with later developed BPSD and reported having ADHD first. CONCLUSIONS: In a cohort selected for symptoms of mania at age 6-12, baseline ADHD was not a significant prospective risk factor for developing BPSD. However, persistence of ADHD may marginally mediate risk of BPSD, and early comorbidity of both diagnoses increases severity/impairment. En ligne : http://dx.doi.org/10.1111/jcpp.13122 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=415 [article] Development of bipolar disorder and other comorbidity among youth with attention-deficit/hyperactivity disorder [texte imprimé] / L. Eugene ARNOLD, Auteur ; Anna R. VAN METER, Auteur ; Mary A. FRISTAD, Auteur ; Eric A. YOUNGSTROM, Auteur ; Boris BIRMAHER, Auteur ; Robert L. FINDLING, Auteur ; Sarah M. HORWITZ, Auteur ; Sarah R. BLACK, Auteur . - p.175-181. Langues : Anglais (eng) in Journal of Child Psychology and Psychiatry > 61-2 (February 2020) . - p.175-181 Mots-clés : Attention-deficit/hyperactivity disorder  bipolar disorder  comorbidity Index. décimale : PER Périodiques Résumé : OBJECTIVE: To examine development of bipolar spectrum disorders (BPSD) and other disorders in prospectively followed children with attention-deficit/hyperactivity disorder (ADHD). METHOD: In the Longitudinal Assessment of Manic Symptoms (LAMS) study, 531 of 685 children age 6-12 (most selected for scores > 12 on General Behavior Inventory 10-item Mania scale) had ADHD, 112 with BPSD, and 419 without. With annual assessments for 8 years, retention averaged 6.2 years. Chi-square analyses compared rate of new BPSD and other comorbidity between those with versus without baseline ADHD and between retained versus resolved ADHD diagnosis. Cox regression tested factors influencing speed of BPSD onset. RESULTS: Of 419 with baseline ADHD but not BPSD, 52 (12.4%) developed BPSD, compared with 16 of 110 (14.5%) without either baseline diagnosis. Those who developed BPSD had more nonmood comorbidity over the follow-up than those who did not develop BPSD (p = .0001). Of 170 who still had ADHD at eight-year follow-up (and not baseline BPSD), 26 (15.3%) had developed BPSD, compared with 16 of 186 (8.6%) who had ADHD without BPSD at baseline but lost the ADHD diagnosis (chi(2) = 3.82, p = .051). There was no statistical difference in whether ADHD persisted or not across new BPSD subtypes (chi(2) = 1.62, p = .446). Of those who developed BPSD, speed of onset was not significantly related to baseline ADHD (p = .566), baseline anxiety (p = .121), baseline depression (p = .185), baseline disruptive behavior disorder (p = .184), age (B = -.11 p = .092), maternal mania (p = .389), or paternal mania (B = .73, p = .056). Those who started with both diagnoses had more severe symptoms/impairment than those with later developed BPSD and reported having ADHD first. CONCLUSIONS: In a cohort selected for symptoms of mania at age 6-12, baseline ADHD was not a significant prospective risk factor for developing BPSD. However, persistence of ADHD may marginally mediate risk of BPSD, and early comorbidity of both diagnoses increases severity/impairment. En ligne : http://dx.doi.org/10.1111/jcpp.13122 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=415

Omega-3 supplementation associated with improved parent-rated executive function in youth with mood disorders: secondary analyses of the omega 3 and therapy (OATS) trials / Anthony T. VESCO in Journal of Child Psychology and Psychiatry, 59-6 (June 2018)  

Public ISBD [article]  inJournal of Child Psychology and Psychiatry > 59-6 (June 2018) . - p.628-636 Titre : Omega-3 supplementation associated with improved parent-rated executive function in youth with mood disorders: secondary analyses of the omega 3 and therapy (OATS) trials Type de document : texte imprimé Auteurs : Anthony T. VESCO, Auteur ; Andrea S. YOUNG, Auteur ; L. Eugene ARNOLD, Auteur ; Mary A. FRISTAD, Auteur Article en page(s) : p.628-636 Langues : Anglais (eng) Mots-clés : School children  bipolar disorder  depression  nutrition  psychotherapy Index. décimale : PER Périodiques Résumé : BACKGROUND: Improvements in executive functioning (EF) may lead to improved quality of life and lessened functional impairment for children with mood disorders. The aim was to assess the impact of omega-3 supplementation (Omega3) and psychoeducational psychotherapy (PEP), each alone and in combination, on EF in youth with mood disorders. We completed secondary analyses of two randomized controlled trials (RCTs) of Omega3 and PEP for children with depression and bipolar disorder. METHODS: Ninety-five youths with depression or bipolar disorder not otherwise specified/cyclothymic disorder were randomized in 12-week RCTs. Two capsules (Omega3 or placebo) were given twice daily (1.87 g Omega3 total daily, mostly eicosapentaenoic acid). Families randomized to PEP participated in twice-weekly 50-min sessions. Analyses assess impact of interventions on the Behavior Rating Inventory of Executive Functioning (BRIEF) parent-report Global Executive Composite (GEC) and two subscales, Behavior Regulation (BRI) and Metacognition (MI) Indices. Intent-to-treat repeated measures ANOVAs, using multiple imputation for missing data, included all 95 randomized participants. Trials were registered with www.clinicaltrials.gov, NCT01341925 & NCT01507753. RESULTS: Participants receiving Omega3 (aggregating combined and monotherapy) improved significantly more than aggregated placebo on GEC (p = .001, d = .70), BRI (p = .004, d = .49), and MI (p = .04, d = .41). Omega3 alone (d = .49) and combined with PEP (d = .67) each surpassed placebo on GEC. Moderation by attention-deficit/hyperactivity disorder (ADHD) comorbidity was nonsignificant although those with ADHD showed nominally greater gains. PEP monotherapy had negligible effect. CONCLUSIONS: Decreased impairment in EF was associated with Omega3 supplementation in youth with mood disorders. Research examining causal associations of Omega3, EF, and mood symptoms is warranted. En ligne : http://dx.doi.org/10.1111/jcpp.12830 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=363 [article] Omega-3 supplementation associated with improved parent-rated executive function in youth with mood disorders: secondary analyses of the omega 3 and therapy (OATS) trials [texte imprimé] / Anthony T. VESCO, Auteur ; Andrea S. YOUNG, Auteur ; L. Eugene ARNOLD, Auteur ; Mary A. FRISTAD, Auteur . - p.628-636. Langues : Anglais (eng) in Journal of Child Psychology and Psychiatry > 59-6 (June 2018) . - p.628-636 Mots-clés : School children  bipolar disorder  depression  nutrition  psychotherapy Index. décimale : PER Périodiques Résumé : BACKGROUND: Improvements in executive functioning (EF) may lead to improved quality of life and lessened functional impairment for children with mood disorders. The aim was to assess the impact of omega-3 supplementation (Omega3) and psychoeducational psychotherapy (PEP), each alone and in combination, on EF in youth with mood disorders. We completed secondary analyses of two randomized controlled trials (RCTs) of Omega3 and PEP for children with depression and bipolar disorder. METHODS: Ninety-five youths with depression or bipolar disorder not otherwise specified/cyclothymic disorder were randomized in 12-week RCTs. Two capsules (Omega3 or placebo) were given twice daily (1.87 g Omega3 total daily, mostly eicosapentaenoic acid). Families randomized to PEP participated in twice-weekly 50-min sessions. Analyses assess impact of interventions on the Behavior Rating Inventory of Executive Functioning (BRIEF) parent-report Global Executive Composite (GEC) and two subscales, Behavior Regulation (BRI) and Metacognition (MI) Indices. Intent-to-treat repeated measures ANOVAs, using multiple imputation for missing data, included all 95 randomized participants. Trials were registered with www.clinicaltrials.gov, NCT01341925 & NCT01507753. RESULTS: Participants receiving Omega3 (aggregating combined and monotherapy) improved significantly more than aggregated placebo on GEC (p = .001, d = .70), BRI (p = .004, d = .49), and MI (p = .04, d = .41). Omega3 alone (d = .49) and combined with PEP (d = .67) each surpassed placebo on GEC. Moderation by attention-deficit/hyperactivity disorder (ADHD) comorbidity was nonsignificant although those with ADHD showed nominally greater gains. PEP monotherapy had negligible effect. CONCLUSIONS: Decreased impairment in EF was associated with Omega3 supplementation in youth with mood disorders. Research examining causal associations of Omega3, EF, and mood symptoms is warranted. En ligne : http://dx.doi.org/10.1111/jcpp.12830 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=363

A systematic review of sensory processing interventions for children with autism spectrum disorders / Jane CASE-SMITH in Autism, 19-2 (February 2015)  

Public ISBD [article]  inAutism > 19-2 (February 2015) . - p.133-148 Titre : A systematic review of sensory processing interventions for children with autism spectrum disorders Type de document : texte imprimé Auteurs : Jane CASE-SMITH, Auteur ; Lindy L. WEAVER, Auteur ; Mary A. FRISTAD, Auteur Article en page(s) : p.133-148 Langues : Anglais (eng) Mots-clés : sensory integration therapy  sensory processing  systematic review Index. décimale : PER Périodiques Résumé : Children with autism spectrum disorders often exhibit co-occurring sensory processing problems and receive interventions that target self-regulation. In current practice, sensory interventions apply different theoretic constructs, focus on different goals, use a variety of sensory modalities, and involve markedly disparate procedures. Previous reviews examined the effects of sensory interventions without acknowledging these inconsistencies. This systematic review examined the research evidence (2000–2012) of two forms of sensory interventions, sensory integration therapy and sensory-based intervention, for children with autism spectrum disorders and concurrent sensory processing problems. A total of 19 studies were reviewed: 5 examined the effects of sensory integration therapy and 14 sensory-based intervention. The studies defined sensory integration therapies as clinic-based interventions that use sensory-rich, child-directed activities to improve a child’s adaptive responses to sensory experiences. Two randomized controlled trials found positive effects for sensory integration therapy on child performance using Goal Attainment Scaling (effect sizes ranging from .72 to 1.62); other studies (Levels III–IV) found positive effects on reducing behaviors linked to sensory problems. Sensory-based interventions are characterized as classroom-based interventions that use single-sensory strategies, for example, weighted vests or therapy balls, to influence a child’s state of arousal. Few positive effects were found in sensory-based intervention studies. Studies of sensory-based interventions suggest that they may not be effective; however, they did not follow recommended protocols or target sensory processing problems. Although small randomized controlled trials resulted in positive effects for sensory integration therapies, additional rigorous trials using manualized protocols for sensory integration therapy are needed to evaluate effects for children with autism spectrum disorders and sensory processing problems. En ligne : http://dx.doi.org/10.1177/1362361313517762 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=256 [article] A systematic review of sensory processing interventions for children with autism spectrum disorders [texte imprimé] / Jane CASE-SMITH, Auteur ; Lindy L. WEAVER, Auteur ; Mary A. FRISTAD, Auteur . - p.133-148. Langues : Anglais (eng) in Autism > 19-2 (February 2015) . - p.133-148 Mots-clés : sensory integration therapy  sensory processing  systematic review Index. décimale : PER Périodiques Résumé : Children with autism spectrum disorders often exhibit co-occurring sensory processing problems and receive interventions that target self-regulation. In current practice, sensory interventions apply different theoretic constructs, focus on different goals, use a variety of sensory modalities, and involve markedly disparate procedures. Previous reviews examined the effects of sensory interventions without acknowledging these inconsistencies. This systematic review examined the research evidence (2000–2012) of two forms of sensory interventions, sensory integration therapy and sensory-based intervention, for children with autism spectrum disorders and concurrent sensory processing problems. A total of 19 studies were reviewed: 5 examined the effects of sensory integration therapy and 14 sensory-based intervention. The studies defined sensory integration therapies as clinic-based interventions that use sensory-rich, child-directed activities to improve a child’s adaptive responses to sensory experiences. Two randomized controlled trials found positive effects for sensory integration therapy on child performance using Goal Attainment Scaling (effect sizes ranging from .72 to 1.62); other studies (Levels III–IV) found positive effects on reducing behaviors linked to sensory problems. Sensory-based interventions are characterized as classroom-based interventions that use single-sensory strategies, for example, weighted vests or therapy balls, to influence a child’s state of arousal. Few positive effects were found in sensory-based intervention studies. Studies of sensory-based interventions suggest that they may not be effective; however, they did not follow recommended protocols or target sensory processing problems. Although small randomized controlled trials resulted in positive effects for sensory integration therapies, additional rigorous trials using manualized protocols for sensory integration therapy are needed to evaluate effects for children with autism spectrum disorders and sensory processing problems. En ligne : http://dx.doi.org/10.1177/1362361313517762 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=256

---

1 (1 - 4 / 4) Par page : 25 50 100 200